Trial Profile
Effect of 50 mg once daily Mirabegron for Ureteral Stent-Related discomfort after Ureteroscopic Procedures
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2018
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- 05 Jun 2018 New trial record
- 26 May 2018 Results published in the BJU International